Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Biosciences Announces the Appointment of Dr. Yiu-Lian Fong, the Former Global Head of Janssen Diagnostic Innovation and R&D at Johnson & Johnson as the New Corporate Director 2024-11-01 15:28
PharmaResearch Hosts 5th Global Symposium on 'Rejuran' 2024-11-01 14:01
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab 2024-11-01 11:34
CARsgen® U.S. Clinical Holds Lifted by FDA 2024-11-01 09:33
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough 2024-10-31 18:00
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK 2024-10-31 13:00
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:34
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024 2024-10-31 10:51
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration 2024-10-31 10:26
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab 2024-10-31 08:46
Latest Updates of Viva Biotech's Portfolio Companies 2024-10-30 22:24
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 2024-10-30 19:00
Changxing Island accelerates development of world-class green petrochemical industrial base 2024-10-30 18:04
World Stroke Congress | TASTE-2 significantly reduces stroke disability 2024-10-30 15:36
Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy 2024-10-30 15:00
Fosun Pharma Announces 2024Q3 Financial Results 2024-10-30 10:41
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year 2024-10-30 08:00
1 10 11 12 13 14 458